Koumprentziotis, I.-A.; Stefanaki, I.; Routsi, E.; Vavouli, C.; Panagakis, P.; Papoutsaki, M.; Politou, M.; Vaiopoulos, A.; Panou, E.; Chasapi, V.;
et al. Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study. J. Clin. Med. 2025, 14, 6472.
https://doi.org/10.3390/jcm14186472
AMA Style
Koumprentziotis I-A, Stefanaki I, Routsi E, Vavouli C, Panagakis P, Papoutsaki M, Politou M, Vaiopoulos A, Panou E, Chasapi V,
et al. Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study. Journal of Clinical Medicine. 2025; 14(18):6472.
https://doi.org/10.3390/jcm14186472
Chicago/Turabian Style
Koumprentziotis, Ioannis-Alexios, Irene Stefanaki, Eleni Routsi, Charitomeni Vavouli, Pantelis Panagakis, Marina Papoutsaki, Maria Politou, Aristeidis Vaiopoulos, Evdoxia Panou, Vasiliki Chasapi,
and et al. 2025. "Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study" Journal of Clinical Medicine 14, no. 18: 6472.
https://doi.org/10.3390/jcm14186472
APA Style
Koumprentziotis, I.-A., Stefanaki, I., Routsi, E., Vavouli, C., Panagakis, P., Papoutsaki, M., Politou, M., Vaiopoulos, A., Panou, E., Chasapi, V., Stratigos, A., & Nicolaidou, E.
(2025). Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study. Journal of Clinical Medicine, 14(18), 6472.
https://doi.org/10.3390/jcm14186472
